SCHEMBL3220923

SCHEMBL3220923

C#C[CH]c1ccccc1Br

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 3/20 0.42
MAPT P10636 5/20 0.39
IKBKB O14920 1/20 0.37
DYRK2 Q92630 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
KMT2A Q03164 4/20 0.36
ATM Q13315 1/20 0.36
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
MEN1 O00255 1/20 0.34
GAA P10253 1/20 0.34
TP53 P04637 1/20 0.34
NFKB1 P19838 1/20 0.34
HTT P42858 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
ALDH1A1 P00352 2/20 0.33
PDGFRB P09619 1/20 0.33
FGFR1 P11362 1/20 0.33
FGFR3 P22607 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7860971 0.76 HSD11B1 (0.42) HSD11B1MAPTIKBKBDYRK2SMN1; SMN2
SCHEMBL3230298 0.73 ALDH1A1 (0.52) MAPTDYRK2KMT2ANPC1RAB9A
SCHEMBL694675 0.72
SCHEMBL3221664 0.71 CYP3A4 (0.41) MAPTSMN1; SMN2KMT2ANPC1RAB9A
SCHEMBL3219076 0.71 TSHR (0.50) MAPTSMN1; SMN2KMT2ANPC1RAB9A
SCHEMBL3211630 0.71 TRIM24 (0.50) MAPTSMN1; SMN2KMT2ANPC1RAB9A
SCHEMBL3225515 0.71 NFE2L2 (0.54) IKBKBDYRK2
SCHEMBL7581010 0.71 MAPT (0.40) HSD11B1MAPTSMN1; SMN2KMT2AATM
SCHEMBL1751871 0.71 HSD11B1 (0.62) HSD11B1IKBKBDYRK2SMN1; SMN2KMT2A
SCHEMBL31613215 0.71 HSD11B1 (0.62) HSD11B1IKBKBDYRK2SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534664-A1 N-BISARYL- AND N-ARYL-CYCLOALKYLIDENYL-ALPHA-HYDROXY-AND ALPHA-ALKOXY ACID AMIDES Syngenta Participations AG (CH) 2005-06-01 EP claimed
WO-2004011417-A1 N-BISARYL- AND N-ARYL-CYCLOALKYLIDENYL-ALPHA-HYDROXY-AND ALPHA-ALKOXY ACID AMIDES SYNGENTA PARTICIPATIONS AG (CH) 2004-02-05 WO claimed
US-20100069244-A1 Pyridine Compounds for Combating Pests BASF SE (DE) 2010-03-18 US disclosed
EP-1534664-A1 N-BISARYL- AND N-ARYL-CYCLOALKYLIDENYL-ALPHA-HYDROXY-AND ALPHA-ALKOXY ACID AMIDES Syngenta Participations AG (CH) 2005-06-01 EP disclosed
WO-2004011417-A1 N-BISARYL- AND N-ARYL-CYCLOALKYLIDENYL-ALPHA-HYDROXY-AND ALPHA-ALKOXY ACID AMIDES SYNGENTA PARTICIPATIONS AG (CH) 2004-02-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069244-A1 Pyridine Compounds for Combating Pests CHRM1, PRDX1, CHRM2 HSD11B1 4263/4885MAPT 4388/4885IKBKB 4613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.